SERVIER
LIVE

Serial Number

79364527

Owner

LES LABORATOIRES SERVIER

Attorney

Maury M. Tepper, III

Filing Date

Nov 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SERVIER Trademark

Serial Number: 79364527 • Registration: 7656296

SERVIER is a trademark filed by LES LABORATOIRES SERVIER on November 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

LES LABORATOIRES SERVIER (15 trademarks)

ORLEANS , FR

Entity Type: 03

Trademark Details

Filing Date

November 29, 2022

Registration Date

January 21, 2025

Published for Opposition

December 3, 2024

Goods & Services

Scientific, optical, weighing, measuring, signaling, checking, inspecting, life-saving and teaching apparatus and instruments, namely, computers and microscopes; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity, namely, electric current transformers, electrical power distribution units; apparatus for sound or image recording, transmission and reproduction; magnetic recording media, namely, blank magnetic disks; data and data information processing apparatus and equipment, namely, couplers; sound recording disks, namely, blank audio discs; digital recording media, namely, blank magnetic disks; data and data information processing apparatus and equipment; software, namely, downloadable software for processing digital images of the anatomy for diagnostic and treatment; downloadable computer programs for managing electronic data and databases, database administration, managing cloud applications, and self-automation of database-management activities; computers; software recorded on magnetic media or downloaded from a remote computer network for the analysis, storage and monitoring of medical data; downloadable computer software applications for providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; telecommunication equipment for use with mobile networks, namely, telecommunication exchangers, telecommunications transmitters; personal digital assistant; electronic signal transmitters; connected bracelets being measuring instruments, namely, wearable activity trackers; connected scales being electronic scales; connected watches as measuring instruments, namely, smart watches; video cameras; electronic proximity sensors; downloadable mobile applications for providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; digital applications, namely, downloadable mobile applications for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; software incorporating algorithms, namely, downloadable computer software for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; artificial intelligence software, namely, downloadable computer software using artificial intelligence for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; downloadable computer software platforms in the form of information sharing software for providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; connected self-measurement instruments being scales; encoded electronic chip cards connected to an information system containing programming used for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; downloadable applications for mobile devices for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; spectacles; contact lenses; smart glasses; in-ear headphones; downloadable telemedicine applications for mobile devices; downloadable augmented reality software for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; downloadable virtual reality computer programs for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; analysis systems based on artificial intelligence, namely, downloadable computer software using artificial intelligence for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; medical image analysis systems based on artificial intelligence, namely, downloadable computer software using artificial intelligence for medical imaging; virtual reality headsets

Pharmaceuticals, namely, pharmaceutical preparations for the treatment of cardiovascular diseases, pharmaceutical preparations for preventing and treating disorders of the central nervous system, cytostatic pharmaceutical preparations for use in the treatment of cancer, pharmaceutical preparations for preventing and treating metabolism disorders, pharmaceutical preparations for the treatment and prevention of obesity, pharmaceutical preparations for the treatment and prevention of diabetes, pharmaceutical preparations for treating blood and blood forming organs to aid in blood clotting, pharmaceutical preparations for the treatment and prevention of disorders of the respiratory system, pharmaceutical preparations for the treatment and prevention of disorders of the musculo-skeletal system, pharmaceutical preparations for the treatment and prevention of disorders of the genitourinary system, anti-infective pharmaceutical preparations, pharmaceutical preparations for the treatment and prevention of disorders of the ophthalmological system

Medical services; veterinary services; hygienic and beauty care for human beings or animals; advice with respect to health, namely, advisory services relating to heath; consultation with respect to pharmacy, namely, pharmaceutical consultation; health services, namely, healthcare; telemedicine services; therapeutic services, namely, physical therapy; medical diagnosis of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; home health care care services; individualized medical prescription services, namely, preparation of prescriptions by pharmacists; online medical prescription services, namely, preparation of prescriptions by pharmacists; providing support in the monitoring of patients receiving medical treatment, namely, remote monitoring of medical data for medical diagnosis and treatment; consultancy in relation to medical treatment in the home; consultancy regarding self-medication; medical information services for patients; remote medical examination services; advice concerning personal well-being in the nature of advisory services relating to health; medical monitoring of patients including provided remotely for medical diagnosis and treatment purposes

Medical, surgical, dental and veterinary apparatus, instruments and equipment for the prevention and treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; artificial limbs, organs being artificial hearts, eyes and teeth; orthopedic articles, namely, orthopedic braces, orthopedic belts; surgical instruments for use in orthopedic surgery; medical, surgical and orthopedic implants made of artificial materials; suture materials; compression stockings, tights and socks; stockings, tights and socks for varicose veins; bandages for compression dressing; medical apparatus, instruments and equipment for introducing pharmaceutical preparations into the human body, particularly for prolonged, controlled or immediate release of active substances; infusion devices for administering drugs and syringes for medical use; medical measuring instruments, in particular instruments able to directly transmit data to a database, in particular instruments to measure fevers, heart rate monitors; apparatus, instruments and equipment derived from robotics for medical use, namely, surgical robots; nanobots for medical use in the nature of surgical robots; apparatus, instruments and equipment derived from bionics for medical use for the prevention and treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; medical devices, namely, connected materials for medical use in the nature of suture materials; medical devices, namely, smart materials for medical use in the nature of implants consisting primarily of artificial materials and also including biological materials; medical diagnostic apparatus for allergy tests; blood testing apparatus; medical devices intended for ingestion, namely, endoscopy camera for medical purposes; endoscopic equipment for medical purposes in the nature of video capsules; medical apparatus for measuring biochemical changes in blood; blood biomarker devices in the nature of blood testing apparatus; medical endoscopy apparatus, namely, medical instruments for use in endoscopy procedures; inhalers for medical purposes, sold empty; blood pressure monitors; physiological monitoring and measuring apparatus for medical use, namely, for measuring and monitoring blood pressure, lung capacity for use in the field of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; telemetry apparatus for medical use; acupuncture instruments; hearing aids; automatic analyzers for medical use, namely, hematology analyzers for medical diagnostic uses; medical imaging apparatus; massage apparatus

Scientific and technological services as well as research and design services relating thereto, namely, scientific research, technological research, and new product design services in the fields of pharmaceuticals and bio-chemicals for the prevention and treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; industrial analysis and research services, namely, industrial research in the fields of pharmaceuticals and bio-chemicals for the prevention and treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; scientific research services for medical research purposes; design and development of computer hardware and software; research, design and development of new products for others, namely, medical tools for monitoring, diagnosis, prediction, analysis; medical and scientific research, namely, conducting clinical trials for others; scientific laboratory services; evaluation, scientific and technical project studies in the nature of technical research in the field of pharmaceutical studies; providing virtual computer systems through cloud computing; rental of computer software for medical research and collaboration; updating of computer software; programming for computers; research and development of new products for third parties; electronic data storage; hosting platforms on the Internet, hosting of web sites; temporary provision of non-downloadable software applications accessible via an Internet site, namely, providing temporary use of a web-based software application for medical research and collaboration; web site design services on the Internet, especially collaborative platforms; engineering design services relating to robotics; development of software directed at patients

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 22, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 31, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 31, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 21, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 30, 2024 RFNT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 14, 2024 OPNX
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 5, 2024 RFCS
REFUSAL PROCESSED BY MPU
Sep 5, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 5, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 3, 2024 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Aug 27, 2024 RFWR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 7, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 7, 2024 OPNR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 13, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 12, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 14, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 9, 2023 REPR